Viewing Study NCT03007732


Ignite Creation Date: 2025-12-24 @ 9:24 PM
Ignite Modification Date: 2026-01-02 @ 4:11 PM
Study NCT ID: NCT03007732
Status: COMPLETED
Last Update Posted: 2025-12-05
First Post: 2016-08-05
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Pembrolizumab +/- SD-101 in Hormone-Naïve Oligometastatic Prostate Cancer With RT and iADT
Sponsor: David Oh
Organization: